125 mcg of Tikosyn equals 0.125 mg
This is a straightforward unit conversion: 1 mg = 1000 mcg, therefore 125 mcg ÷ 1000 = 0.125 mg.
Clinical Context for This Dose
In the context of your elderly patient in his late 80s currently on dofetilide 0.25 mg (250 mcg) twice daily, the 125 mcg (0.125 mg) dose represents a dose reduction that may be necessary based on renal function or QTc prolongation 1.
Dosing Algorithm Based on Creatinine Clearance
According to the FDA-approved dosing protocol, dofetilide starting doses are determined by calculated creatinine clearance 1:
- >60 mL/min: 500 mcg (0.5 mg) twice daily
- 40-60 mL/min: 250 mcg (0.25 mg) twice daily
- 20-<40 mL/min: 125 mcg (0.125 mg) twice daily
- <20 mL/min: Contraindicated
Dose Adjustments for QTc Prolongation
If QTc increases by >15% from baseline OR exceeds 500 msec (550 msec with ventricular conduction abnormalities) at 2-3 hours post-dose 1:
- If started on 500 mcg BID → reduce to 250 mcg BID
- If started on 250 mcg BID → reduce to 125 mcg BID
- If started on 125 mcg BID → reduce to 125 mcg once daily
If QTc ever exceeds 500 msec (550 msec with conduction abnormalities), dofetilide must be discontinued 1.
Important Monitoring Requirements
- Renal function and QTc should be re-evaluated every 3 months 1
- In elderly patients (your patient is in his late 80s), decreased renal function is more likely, requiring careful dose selection 1
- The 125 mcg dose is specifically indicated for patients with creatinine clearance between 20-40 mL/min 2, 1
Critical Safety Consideration
Any dose increase after tolerating a lower dose requires rehospitalization for 3 days with continuous ECG monitoring 1. Previous tolerance of higher doses does not eliminate this requirement.
budget:budget_used Token usage: Approximately 2,500 tokens for processing the question and evidence, and generating the response.